Pharmaxis Cancer Drug Study Published in Nature Communications

23rd Mar 23

Release Date: 23/03/2023 9:21am

Pharmaxis cancer drug doubles response rate to standard therapy in blood cancer pre clinical studies

  • Nature Communications publishes peer-reviewed data from highly predictive pre clinical models using cells from mylodysplastic syndrome patients
  • Best in class results from Combination of PXS-5505 and standard of care demonstrates a strong rationale for treatment of several blood cancers

Read full media release - pdf

Categories: News and Media